10 likes | 118 Views
4000. 20. 2.0. 15000. 3000. 15. 1.5. 10000. % CD4+ Flt3L. % CD4+ Flt3L+. MFI Flt3L. MFI Flt3L. 10. 2000. 1.0. 5000. 0.5. 5. 1000. 0.0. 0. 0. 0. PB HI. PB RA. SF RA. PB HI. PB RA. SF RA. PB HI. PB RA. SF RA. PB HI. PB RA. SF RA. 4000. 2.0. 10000. 15. 8000.
E N D
4000 20 2.0 15000 3000 15 1.5 10000 % CD4+ Flt3L % CD4+ Flt3L+ MFI Flt3L MFI Flt3L 10 2000 1.0 5000 0.5 5 1000 0.0 0 0 0 PB HI PB RA SF RA PB HI PB RA SF RA PB HI PB RA SF RA PB HI PB RA SF RA 4000 2.0 10000 15 8000 3000 1.5 10 6000 % CD8+ Flt3L MFI Flt3L MFI Flt3L 2000 1.0 % CD8+ Flt3L+ 4000 0.5 5 1000 2000 0.0 0 0 PB HI PB RA SF RA PB HI PB RA SF RA 0 PB HI PB RA SF RA PB HI PB RA SF RA 3000 150 5 15000 4 2000 100 10000 % CD19+ Flt3L 3 MFI Flt3L % CD19+ Flt3L+ MFI Flt3L 50 1000 2 5000 1 0 0 PB HI PB RA SF RA 0 0 PB HI PB RA SF RA PB HI PB RA SF RA PB HI PB RA SF RA Extracelullar Intracelullar % MFI % MFI A CD4+ Tcells B CD8+ T cells C CD19+ B cells M.I.P.Ramos Supplementary Figure 2